Celularity (CELU) vs Grace Therapeutics (GRCE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Celularity (CELU) has outperformed Grace Therapeutics (GRCE) over the past year, losing 27.9% versus a loss of 30.5%. Over five years, GRCE leads with a -79.9% price change compared with -98.0% for CELU. Celularity is the larger company by market cap ($47.1 million vs $42.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CELU | GRCE |
|---|---|---|
| Share price | $1.45 | $2.02 |
| Market cap | $47.05M | $42.49M |
| 1-day change | -1.36% | -3.81% |
| YTD return | +32.43% | -39.31% |
| 1-year return | -27.94% | -30.46% |
| 5-year return | -97.96% | -79.89% |
| EPS (TTM) | $-2.73 | $-1.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.55 | $5.18 |
| 52-week low | $0.56 | $1.79 |
| Distance from 52-week high | -43.14% | -61.00% |
| Average volume | 3.89M | 171.87K |
| Shares outstanding | 32.45M | 21.04M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CELU vs GRCE FAQ
Which is bigger, Celularity or Grace Therapeutics?
Celularity (CELU) is larger, with a market capitalization of $47.05M compared with $42.49M for Grace Therapeutics (GRCE).
Which stock has performed better over the past year, CELU or GRCE?
CELU returned -27.94% over the past 12 months, compared with -30.46% for GRCE (price return, excluding dividends). Past performance does not predict future results.
Are Celularity and Grace Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.